Batch recall of three allopurinol-containing products
The Department of Health (DH) today (May 5) endorsed a licensed drug wholesaler, Welldone Pharmaceuticals Limited (Welldone), to recall three allopurinol-containing products namely Tospan Allopurinol Tablets 300mg (HK-66537) with batch number 22D00 2022-027, Willipo Allopurinol Tablets 300mg (HK-66538) with batch number 22D00 2022-026 and Eformat Allopurinol Tablets 300mg (HK-66534) with batch number 22D00 2022-025 from the market.
Testing result from the Government Laboratory showed that the sample failed the dissolution test, which might affect the efficacy of the products. Welldone thus voluntarily recalled the products from the market.
The above products, containing allopurinol, are prescription-only medicines indicated mainly for hyperuricaemia and gout. According to Welldone, the products have been supplied to local pharmacies and re-exported to Macau.
Welldone has set up a hotline (2121 0542) to answer related enquiries. The DH will closely monitor the recall.
So far, the DH has not received any adverse reaction reports in connection with the above products.
Ends/Friday, May 5, 2023